ESC Professional Premium Access

Cardio-oncology 4

Event: ESC Congress 2022
Topic: Cardio-Oncology
Session type: Moderated ePosters
Date: 27 August 2022
Time: 11:15 - 11:55

Congress Session

7 presentations in this session

Basal characteristics of the prospective spanish immunotherapy registry of cardiovascular toxicity: SIR-CVT

Speaker: Doctor E. Zatarain-Nicolas (Madrid, ES)

The prognostic significance of troponin level in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study)

Speaker: Doctor A. Kaura (London, GB)

COVID-19 and acute heart failure among patients with cancer

Speaker: Doctor M. Bergami (Bologna, IT)

Effect of 1st line treatment on aortic inflammation as assessed by 18 FDG PET/CT in patients with Hodgkin and non-Hodgkin lymphoma

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up

Speaker: Doctor A. Daniele (Buenos Aires, AR)

Prognostic impact of coronary artery calcifications in patients with newly diagnosed prostate cancer

Speaker: Doctor N. Stoedkilde-Joergensen (Aarhus, DK)

Prediction of anthracycline-induced cardiotoxicity as assessed by global longitudinal strain in women with early breast cancer: Insights from the PRADA trial

Speaker: Doctor A. Mecinaj (Nordbyhagen, NO)

7 speakers from this session

Doctor Eduardo Zatarain-Nicolas

University Hospital Gregorio Maranon, Madrid (Spain)
1 presentation
0 follower

Doctor Amit Kaura

Imperial College Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Maria Bergami

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)
0 follower

Doctor Dimitrios Terentes-Printzios

National & Kapodistrian University of Athens, Athens (Greece)
1 presentation
0 follower

Doctor Andres Jose Daniele

Institute of Oncology Angel H. Roffo, Buenos Aires (Argentina)
0 follower

Doctor Nina Stoedkilde-Joergensen

Aarhus University Hospital, Aarhus (Denmark)
0 follower

Doctor Albulena Mecinaj

Akershus University Hospital, Nordbyhagen (Norway)
0 follower

This platform is supported by

logo Novo Nordisk